Assessing Blood Flow Responses in Healthy Young Adults

Comparing Approaches to Assess Nitric Oxide-dependent Cutaneous Vasodilation

Recruiting Early Phase 1 Interventional Study
Endothelial Function
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 30
Sex
Any
Trial phase
Early Phase 1
Study type
Interventional
Purpose
Basic Science
Participants needed
56 (estimated)
Sponsor
University of Iowa · Other
Who this trial is looking for

This trial is looking for healthy young adults aged 18 to 30. Participants will undergo skin heating experiments to understand how their blood vessels respond.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am a man or woman
  • I am between 18 and 30 years old

You may not be able to join if

  • I have used medication in the last 8 weeks that affects blood vessels
  • I have changed my medication recently
  • I have a chronic disease like heart disease or diabetes
  • My body mass index is less than 18.5 or greater than 35
  • I am pregnant or breastfeeding
  • I have allergies to study drugs
  • I do not understand English

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The increase in skin blood flow in response to rapid local heating of the skin (i.e., cutaneous vasodilation) is commonly used to assess nitric oxide (NO)-dependent dilation and overall microvascular function. Historically, rapid local heating to 42°C was considered the standard approach for these assessments. More recently, many investigators have adopted rapid local to 39°C instead, based on its…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * men and women * 18-30 years of age Exclusion Criteria: * Current or recent (within 8 wks) use of medication that could conceivably alter microvascular function \[including (but not limited to) stimulants, antihypertensives, HMG-CoA reductase inhibitors\] * Changes or alterat…
Contacts

Anna Stanhewicz, PhD

3194671732

anna-stanhewicz@uiowa.edu

CONTACT